NANOREPRO AG (NN6.DE) Stock Price & Overview
FRA:NN6 • DE0006577109
Current stock price
The current stock price of NN6.DE is 1.415 EUR. Today NN6.DE is down by -0.35%. In the past month the price decreased by -9%. In the past year, price decreased by -2.75%.
NN6.DE Key Statistics
- Market Cap
- 18.254M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.14
- Dividend Yield
- 6.98%
NN6.DE Stock Performance
NN6.DE Stock Chart
NN6.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NN6.DE. When comparing the yearly performance of all stocks, NN6.DE is a bad performer in the overall market: 75.85% of all stocks are doing better.
NN6.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NN6.DE. No worries on liquidiy or solvency for NN6.DE as it has an excellent financial health rating, but there are worries on the profitability.
NN6.DE Earnings
NN6.DE Forecast & Estimates
5 analysts have analysed NN6.DE and the average price target is 4.59 EUR. This implies a price increase of 224.38% is expected in the next year compared to the current price of 1.415.
For the next year, analysts expect an EPS growth of -1% and a revenue growth 232.82% for NN6.DE
NN6.DE Groups
Sector & Classification
NN6.DE Financial Highlights
Over the last trailing twelve months NN6.DE reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS increased by 39.13% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.53% | ||
| ROE | -4.65% | ||
| Debt/Equity | 0 |
NN6.DE Ownership
NN6.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 14.19 | 97.113B | ||
| SHL | SIEMENS HEALTHINEERS AG | 13.78 | 40.337B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 15.3 | 22.61B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.33 | 22.571B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 15.31 | 22.552B | ||
| BIM | BIOMERIEUX | 18.76 | 10.581B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 17.49 | 3.369B | ||
| DIA | DIASORIN SPA | 14.35 | 3.26B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.83 | 2.175B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.45 | 1.692B | ||
| DRW8 | DRAEGERWERK AG | 8.59 | 1.291B | ||
| ELN | EL.EN. SPA | 15.66 | 979.832M | ||
| EUZ | ECKERT & ZIEGLER SE | 17.35 | 928.027M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About NN6.DE
Company Profile
NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. The company is headquartered in Marburg An Der Lahn, Hessen and currently employs 20 full-time employees. The company went IPO on 2012-10-09. The firm is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.
Company Info
IPO: 2012-10-09
NANOREPRO AG
Untergasse 8
Marburg an der Lahn HESSEN DE
Employees: 21
Phone: 496421951449
NANOREPRO AG / NN6.DE FAQ
What does NANOREPRO AG do?
NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. The company is headquartered in Marburg An Der Lahn, Hessen and currently employs 20 full-time employees. The company went IPO on 2012-10-09. The firm is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.
What is the stock price of NANOREPRO AG today?
The current stock price of NN6.DE is 1.415 EUR. The price decreased by -0.35% in the last trading session.
Does NN6 stock pay dividends?
NANOREPRO AG (NN6.DE) has a dividend yield of 6.98%. The yearly dividend amount is currently 0.15.
What is the ChartMill technical and fundamental rating of NN6 stock?
NN6.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the GICS sector and industry of NN6 stock?
NANOREPRO AG (NN6.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Who owns NANOREPRO AG?
You can find the ownership structure of NANOREPRO AG (NN6.DE) on the Ownership tab.